Rycarfa 50mg Tablets for dogs

Rycarfa Tablets For Dogs

Rycarfa tablets help manage pain experienced by your dog, such as post-operative pain, symptoms of degenerative joint disease and musculoskeletal disorders. Many of these conditions require careful clinical management, and an anti-inflammatory like rycarfa helps dogs suffering from these issues and similar health conditions.

This non-steroidal anti-inflammatory agent is available to buy online; however, a prescription is required before we ship your dog's medication. If your dog experiences an adverse reaction, seek medical advice immediately from a qualified vet. Rycarfa reduces inflammation and pain caused by musculoskeletal disorders and degenerative joint disease. As a follow up to parenteral analgesia in the management of post operative pain.

How To Buy Rycarfa For Dogs

Rycarfa dog tablets are a prescription-only medication. This means that before you complete your purchase, you are required to upload a prescription through our online portal. After our team has confirmed you've ordered the right medication for your dog, we can send out your order. It's a simple process that means you can buy rycarfa dog medication online instead of going to your vet every month.

How To Use Rycarfa For Dogs

For oral administration. 2 to 4 mg carprofen per kg body weight per day. An initial dose of 4 mg carprofen per kg body weight per day given as a single daily dose or in two equally divided doses may, subject to clinical response, be reduced after seven days to 2 mg carprofen/kg body weight/day given as a single dose. Duration of treatment will be dependent upon the response seen. Long term treatment should be under regular veterinary supervision.

Target species

Dogs

4.2 Indications for use, specifying the target species

Reduction of inflammation and pain caused by musculoskeletal disorders and degenerative joint disease. As a follow up to parenteral analgesia in the management of post-operative pain.

4.3 Contraindications

Do not use in cats. Do not use in pregnant or lactating bitches. Do not use in dogs less than 4 months of age. Do not use in cases of hypersensitivity to the active substance or to any of the excipients. Do not use in dogs suffering from cardiac, hepatic or renal disease, where there is a possibility of gastrointestinal ulceration or bleeding, or where there is evidence of a blood dyscrasia.

4.4 Special warnings for each target species

Refer to Sections 4.3 and 4.5.

4.5 Special precautions for use

Special precautions for use in animals

Use in aged dogs may involve additional risk. If such a use cannot be avoided, dogs may require careful clinical management. Avoid use in any dehydrated, hypovolaemic or hypotensive dog, as there is a potential risk of increased renal toxicity. NSAIDs can cause inhibition of phagocytosis and hence in the treatment of inflammatory conditions associated with bacterial infection, appropriate concurrent antimicrobial therapy should be instigated. See section 4.8. The tablets are flavoured. In order to avoid any accidental ingestion, store tablets out of reach of the animals.

Special precautions to be taken by the person administering the veterinary medicinal product to animals

In the event of accidental ingestion of the tablets, seek medical advice and show the doctor the package leaflet. Wash hands after handling the product.

4.6 Adverse reactions (frequency and seriousness)

Typical undesirable effects associated with NSAIDs such as vomiting, soft faeces/diarrhoea, faecal occult blood, loss of appetite and lethargy have been reported. These adverse reactions occur generally within the first treatment week and are in most cases transient and disappear following termination of the treatment but in very rare cases may be serious or fatal.

If adverse reactions occur, use of the product should be stopped and the advice of a veterinarian should be sought.

As with other NSAIDs there is a risk of rare renal or idiosyncratic hepatic adverse events.

The frequency of adverse reactions is defined using the following convention:

• very common (more than 1 in 10 animals treated displaying adverse reaction(s))
• common (more than 1 but less than 10 animals in 100 animals treated)
• uncommon (more than 1 but less than 10 animals in 1,000 animals treated)
• rare (more than 1 but less than 10 animals in 10,000 animals treated)
• very rare (less than 1 animal in 10,000 animals treated, including isolated reports).

4.7 Use during pregnancy, lactation or lay

Studies in laboratory species (rat and rabbit) have shown evidence of foetotoxic effects of carprofen at doses close to the therapeutic dose. The safety of the veterinary medicinal product has not been established during pregnancy and lactation. Do not use in pregnant or lactating bitches.

4.8 Interaction with other medicinal products and other forms of interaction

Do not administer other NSAIDs and glucocorticoids concurrently or within 24 hours of administration of the product. Carprofen is highly bound to plasma proteins and may compete with other highly bound drugs, which can lead to toxic effects.

Concurrent administration of potential nephrotoxic drugs should be avoided.